Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
07-2013 | 12-2012 | 12-2006 | |
Assets | |||
Current Assets | |||
Cash & Cash Equivalents | 599 | 599 | N/A |
Other current assets | 0 | 21 | 0 |
TOTAL | $620 | $620 | $N/A |
Non-Current Assets | |||
Intangibles | 23 | 0 | 0 |
TOTAL | $23 | $N/A | $N/A |
Total Assets | $643 | $643 | $N/A |
Liabilities | |||
Current Liabilities | |||
Short Term Debt | 350 | N/A | N/A |
Accounts payable and accrued liabilities | 41 | 0 | 0 |
Accrued Expenses | 458 | N/A | N/A |
Other current liabilities | 10 | N/A | N/A |
TOTAL | $883 | $883 | $N/A |
Non-Current Liabilities | |||
TOTAL | $750 | $N/A | $N/A |
Total Liabilities | $1,633 | $1,633 | $N/A |
Shareholders' Equity | |||
Common Shares | 165 | N/A | N/A |
Retained earnings | -34,850 | -34,850 | N/A |
Other shareholders' equity | 0 | 33,860 | 0 |
TOTAL | $-990 | $-990 | $N/A |
Total Liabilities And Equity | $643 | $643 | $0 |